- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | Eton Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 22.03. | Eton Pharmaceuticals, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 22.03. | Eton Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.03. | Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE | 3 | Seeking Alpha | ||
| 22.03. | Relief Therapeutics schliesst US-Lizenz und Liefervereinbarung mit Eton Pharma | 14 | cash | ||
| 22.03. | Eton Pharma Buys U.S. Rights To PKU GOLIKE From Relief Therapeutics | 4 | RTTNews | ||
| 22.03. | Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria | 1 | GlobeNewswire (USA) | ||
| 22.03. | Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE | 1.584 | EQS Group (EN) | Relief Therapeutics Holding SA / Key word(s): Partnership
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
22-March-2024... ► Artikel lesen | |
| 15.03. | Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 15.03. | Earnings call: Eton Pharmaceuticals reports robust Q4 growth | 1 | Investing.com | ||
| 14.03. | Eton Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 14.03. | Recap: Eton Pharmaceuticals Q4 Earnings | 1 | Benzinga.com | ||
| 14.03. | Eton Pharmaceuticals, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 14.03. | Eton Pharmaceuticals GAAP EPS of -$0.09 misses by $0.05, revenue of $7.3M misses by $0.36M | 1 | Seeking Alpha | ||
| 14.03. | Eton Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.03. | Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results | 299 | GlobeNewswire (Europe) | Q4 2023 revenue of $7.3 million, representing a 109% increase from Q4 2022, marking the twelfth consecutive quarter of sequential product sales growthFull year 2023 revenues reached $31.6 million... ► Artikel lesen | |
| 13.03. | Eton Pharmaceuticals Earnings Preview | 2 | Benzinga.com | ||
| 29.02. | Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 | 1 | GlobeNewswire (USA) | ||
| 26.02. | Eton Pharma (ETON) to Report Q4 Earnings: What's in the Cards? | 1 | Zacks | ||
| 21.02. | US STOCKS Toll Brothers, Natgas firms, Eton Pharmaceuticals | 2 | Reuters |
Seite:
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 26,460 | -1,87 % | Palantir, Globex Mining, Bayer - Der Trend zeigt nach oben | Nach einem erfolgreichen ersten Börsenquartal des Jahres 2024 gönnten sich DAX und Dow Jones in der vergangenen Woche eine wohl verdiente Verschnaufpause. Dagegen setzten die Edelmetallmärkte um Gold... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 20,510 | +2,35 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 10,400 | +0,97 % | Astria Therapeutics, Inc. - 8-K, Current Report | ||
| ROCKET LAB USA | 3,345 | +0,75 % | TechCrunch Space: True Anomaly and Rocket Lab will make big moves on orbit (literally) | ||
| BOIRON | 34,500 | +0,73 % | BOIRON: Outlook 2023 - Communication calendar 2024 | The Board of Directors of Laboratoires BOIRON met on 19 December 2023, under the chairmanship of Mr Thierry Boiron.
At this meeting, the Board reviewed the latest business and earnings forecasts... ► Artikel lesen | |
| MEDICINOVA | 1,250 | 0,00 % | MediciNova, Inc.: MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) | LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 6,990 | 0,00 % | ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | ||
| AQUESTIVE THERAPEUTICS | 3,930 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics to Present Crossover Study Data for Libervant (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology | ||
| HARROW | 12,360 | -2,29 % | HROW, HCAT and EGRX are among after hour movers | ||
| SHINECO | 0,725 | 0,00 % | Shineco, Inc.: Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement | BEIJING, March 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that... ► Artikel lesen | |
| CYANOTECH | 0,260 | 0,00 % | NSE - CYANOTECH CORP - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| CUMBERLAND PHARMACEUTICALS | 1,630 | 0,00 % | Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Annual 2023 Financial Results | 2023 highlights include expanded FDA approval and new study publications
NASHVILLE, Tenn., March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical... ► Artikel lesen | |
| MERCK KGAA | 152,20 | -0,91 % | Deutsche Bank, Commerzbank, Merck, Sartorius: DAX-Überblick | Nach einem zunächst freundlichen Handelsverlauf ist der DAX (WKN: 846900) am Mittwoch nach Bekanntwerden der Daten zur US-Inflation deutlich ins Minus gerutscht. Aus dem Handel ging es aber +0,11% höher... ► Artikel lesen | |
| ASTRAZENECA | 129,85 | -0,12 % | Ihre wichtigsten Termine: Heute im Blick: AstraZeneca, Frosta, Givaudan, VAT, Gerresheimer, Adecco & Emmi | © Foto: picture alliance/ASSOCIATED PRESS/Gerresheimer AG - picture alliance/ASSOCIATED PRESS/Gerresheimer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick... ► Artikel lesen | |
| NOVO NORDISK | 118,16 | 0,00 % | Novo Nordisk und Eli Lilly: Börsen-Überflieger im Übernahme-Fieber | Guten Tag, liebe Leserinnen und Leser,
das Duo Novo Nordisk und Eli Lilly zählt in diesem Jahr zu den Top-Performern unter den Champions-Aktien und gewann auch massiv an Marktmacht: Der US-Pharmakonzern... ► Artikel lesen |
ETON PHARMACEUTICALS INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -5,81 % bei einem Aktienkurs von 3,240 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
